Cargando…

Long-term survival analysis of masitinib in amyotrophic lateral sclerosis

BACKGROUND: A randomized, placebo-controlled phase III study (AB10015) previously demonstrated that orally administered masitinib (4.5 mg/kg/day) slowed rate of functional decline, with acceptable safety, in amyotrophic lateral sclerosis (ALS) patients having an ALS Functional Rating Scale-revised (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mora, Jesus S., Bradley, Walter G., Chaverri, Delia, Hernández-Barral, María, Mascias, Javier, Gamez, Josep, Gargiulo-Monachelli, Gisella M., Moussy, Alain, Mansfield, Colin D., Hermine, Olivier, Ludolph, Albert C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388186/ https://www.ncbi.nlm.nih.gov/pubmed/34457038 http://dx.doi.org/10.1177/17562864211030365

Ejemplares similares

Neuroprotective effect of masitinib in rats with postischemic stroke
por: Kocic, Ivan, et al.
Publicado: (2014)

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
por: Vermersch, Patrick, et al.
Publicado: (2022)

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
por: Vermersch, Patrick, et al.
Publicado: (2012)

Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
por: Trias, Emiliano, et al.
Publicado: (2016)

Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial
por: Davidescu, Lavinia, et al.
Publicado: (2022)

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
por: Dubois, Bruno, et al.
Publicado: (2023)

Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy
por: Moura, Daniela Silva, et al.
Publicado: (2011)

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
por: Dubreuil, Patrice, et al.
Publicado: (2009)

Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model
por: Humbert, Martine, et al.
Publicado: (2010)

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
por: Dubois, Bruno, et al.
Publicado: (2023)

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
por: Tebib, Jacques, et al.
Publicado: (2009)

Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats
por: Belin-Rauscent, A., et al.
Publicado: (2018)

Non-invasive ventilation in amyotrophic lateral sclerosis
por: Dorst, Johannes, et al.
Publicado: (2019)

Spanish Adaptation of the Dimensional Apathy Scale (DAS) in Amyotrophic Lateral Sclerosis
por: Salas, Teresa, et al.
Publicado: (2020)

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
por: Deplanque, G., et al.
Publicado: (2015)

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
por: Piette, François, et al.
Publicado: (2011)

Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis
por: Dorst, Johannes, et al.
Publicado: (2017)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Skeletal muscle in amyotrophic lateral sclerosis
por: Shefner, Jeremy M, et al.
Publicado: (2023)

More about masitinib
por: Walker, Ulrich A
Publicado: (2009)

The Fragile X Protein Family in Amyotrophic Lateral Sclerosis
por: Mueller, Sarah, et al.
Publicado: (2023)

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial
por: Adenis, A., et al.
Publicado: (2014)

Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
por: Staats, Kim A., et al.
Publicado: (2022)

ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
por: Petrov, Dmitry, et al.
Publicado: (2017)

Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis
por: Lindauer, Eva, et al.
Publicado: (2013)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis
por: Volk, Alexander E., et al.
Publicado: (2018)

Pharyngeal electrical stimulation in amyotrophic lateral sclerosis: a pilot study
por: Herrmann, Christine, et al.
Publicado: (2022)

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)

Diffusion Tensor Imaging in Amyotrophic Lateral Sclerosis: Machine Learning for Biomarker Development
por: Behler, Anna, et al.
Publicado: (2023)

Interaction of Masitinib with Organic Cation Transporters
por: Harrach, Saliha, et al.
Publicado: (2022)

Multimodal in vivo staging in amyotrophic lateral sclerosis using artificial intelligence
por: Behler, Anna, et al.
Publicado: (2022)

Well-being in amyotrophic lateral sclerosis: a pilot experience sampling study
por: Real, Ruben G. L., et al.
Publicado: (2014)

Religiosity in patients with amyotrophic lateral sclerosis, a cross-country comparison
por: Ciećwierska, Katarzyna, et al.
Publicado: (2023)

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
por: Povedano Panades, Mónica, et al.
Publicado: (2021)

Sequential alterations in diffusion metrics as correlates of disease severity in amyotrophic lateral sclerosis
por: Müller, Hans-Peter, et al.
Publicado: (2023)

Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis
por: Lulé, Dorothée, et al.
Publicado: (2019)

Cardiac Findings in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Imaging Study
por: Rosenbohm, Angela, et al.
Publicado: (2017)

Untangling the knot: Lifetime physical exercise and amyotrophic lateral sclerosis
por: Chiò, Adriano, et al.
Publicado: (2021)

CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis
por: Lopez-Lopez, Alan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6svb4m86bgvrfp9ag6gmjfidmu